Esperion to Present Two New Analyses from CLEAR Outcomes Clinical Trial at the American College of Cardiology 2026 Annual Scientific Session
Go back to Esperion to Present Two New Analyses from CLEAR Outcomes Clinical Trial at the American College of Cardiology 2026 Annual Scientific Session| ESPERION THERAP (NASDAQ: ESPR) | Delayed: 3.17 +0.01 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.16 | 52 Week High | $30.41 | |||
| Open | $3.17 | 52 Week Low | $9.40 | |||
| Day High | $3.17 | P/E | N/A | |||
| Day Low | $3.17 | EPS | $-21.87 | |||
| Volume | 1,222 | |||||
